And, as always, these are independent authors with no affiliation with PNV, with no incentive to publish this paper other than wanting to spread the word of these fantastic results (and get some papers under their belt of course).
This is why, in my opinion, sales are going to continue accelerating, rather than inexplicably stagnating like some brokers predict. We are becoming standard of care, but we have barely penetrated the potential market yet.
The Clinicians Speak, page-847
-
- There are more pages in this discussion • 214 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.32 |
Change
-0.020(0.85%) |
Mkt cap ! $1.602B | |||
| Open | High | Low | Value | Volume |
| $2.35 | $2.37 | $2.30 | $2.354M | 1.012M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 11423 | $2.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.33 | 8018 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |